Biostar Pharmaceuticals, Inc. (BSPM.OB) Receives Clearance in China to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
Biostar Pharmaceuticals Inc., through its wholly-owned subsidiary in China, develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The company announced today that the Chinese Military Drug Administration has granted clearance to begin clinical trials on their new drug application, the Zushima Analgesic Aerosol Spray. This product is a traditional Chinese herbal product used to relieve pain through a topical application to affected areas or closed wounds. The spray can also be used in the treatment of certain rheumatic conditions. The product is classified as a “specially needed drug” by the Chinese Military…